CAPSTONE INVESTMENT ADVISORS, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2022$1,077,741
+6.3%
13,7030.0%0.01%
+33.3%
Q3 2022$1,014,000
+13.5%
13,7030.0%0.01%
+50.0%
Q2 2022$893,000
+3.1%
13,7030.0%0.00%
+100.0%
Q1 2022$866,000
+19.1%
13,7030.0%0.00%
+100.0%
Q4 2021$727,000
-24.8%
13,7030.0%0.00%
-50.0%
Q3 2021$967,000
+41.2%
13,703
+33.3%
0.00%0.0%
Q2 2021$685,000
-73.4%
10,277
-55.7%
0.00%
-75.0%
Q1 2021$2,575,000
+781.8%
23,200
+212.9%
0.01%0.0%
Q2 2017$292,0007,4140.01%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders